Full-line prescription drug wholesaling has an intrinsic value, based on carrying and supplying a full range of medicines that benefits governments, manufacturers and patients alike, according to Liam Fitzgerald, chief executive of United Drug, a provider of services to pharmaceutical retailers and manufacturers and Ireland's largest pharmaceutical wholesaler. He was speaking at the 49th Annual General Meeting of the European Association of Pharmaceutical Full-line Wholesalers (GIRP) in Prague, the Czech Republic.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze